Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies

• Caroline Robert,
• Solange Peters,
• Olivier Michielin,
• Padmanee Sharma,
• Aly-Khan Lalani

Affiliations

Caroline Robert

Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France

Solange Peters

Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

Olivier Michielin

Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

Padmanee Sharma

Departments of Genitourinary Medical Oncology and Immunology, UT MD Anderson Cancer Center, Houston, Texas, USA

Aly-Khan Lalani

Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada